Welcome to LookChem.com Sign In|Join Free
  • or
2-(2-chlorophenyl)propan-1-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

26059-47-2

Post Buying Request

26059-47-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26059-47-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 26059-47-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,5 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 26059-47:
(7*2)+(6*6)+(5*0)+(4*5)+(3*9)+(2*4)+(1*7)=112
112 % 10 = 2
So 26059-47-2 is a valid CAS Registry Number.

26059-47-2Relevant academic research and scientific papers

Synthesis of alcohols via a rhodium-catalyzed hydroformylation-reduction sequence using tertiary bidentate amine ligands

Cheung, Lawrence L. W.,Vasapollo, Giuseppe,Alper, Howard

, p. 2019 - 2022 (2012)

The synthesis of alcohols from aromatic olefins is described using a rhodium-catalyzed hydroformylation-reduction sequence with the assistance of a tertiary diamine ligand. The alcohols are produced in excellent branched to linear ratios and in good to excellent isolated yields. In all cases no aldehyde product, from hydroformylation, or alkyl product, from olefin reduction, was detected. Copyright

ANTI-HCMV COMPOSITIONS AND METHODS

-

Page/Page column 32; 33; 49; 50, (2016/06/06)

This document relates to compounds useful as agents for preventing or treating human cytomegalovirus (HCMV) infections.

IMIDAZOLE DERIVATIVES AS IDO INHIBITORS

-

Page/Page column 129, (2011/06/11)

Presently provided are IDO inhibitors of general formulae (VII), (VIII) as shown below and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 26059-47-2